Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Subscribe To Our Newsletter
NGOs call on Global Fund Board to sustain catalytic investments in harm reduction in next allocation cycle
GFO Issue 351

NGOs call on Global Fund Board to sustain catalytic investments in harm reduction in next allocation cycle

Author:

Charlie Baran

Article Type:
Notice

Article Number: 6

Briefing highlights impact of harm reduction investments in MICs

ABSTRACT Harm Reduction International and Frontline AIDS (formerly known as the International HIV/AIDS Alliance) released a joint briefing in January urging the Global Fund Board to sustain investments in harm reduction interventions, in advance of the Fund's upcoming decision at its May Board meeting on its allocation methodology and catalytic funding priorities for the 2020-2022 period.

In January, Harm Reduction International and the International HIV/AIDS Alliance (now Frontline AIDS) released a joint briefing urging the Global Fund Board to sustain investments in harm reduction interventions as the Fund considers its allocation methodology and catalytic funding priorities for the 2020-2022 period. The Global Fund Board will define the revised allocation methodology and catalytic priorities at its May 2019 meeting in Geneva. Final allocation amounts will be decided following the Global Fund’s Sixth Replenishment conference in Lyon, France, to be held in October.

The briefing paper urges the Global Fund Board “to safeguard catalytic investment funds,” including multicountry grants, matching funds, and strategic initiatives. The paper lays out evidence of the impact and rationale for continued Global Fund investments in harm reduction interventions for people who use drugs, including opioid substitution therapy and needle and syringe programs, saying they are, “cost effective, protect against HIV and hepatitis C, and save lives.”

The paper points out that the Global Fund is the largest donor for harm reduction programmes in lower- and middle-income countries, in the order of two-thirds of all international donor support for them. It also describes a number of cases in which the Fund’s catalytic funding for harm reduction has done exactly what was intended: catalyze action and further investment.

The complete briefing is available on Harm Reduction International’s website as a PDF file.

Leave a reply

  • Anonymous comments (0)
  • Facebook Comments

Your email address will not be published.

Aidspan

Categories*

Loading
Aidspan

Categories*

Loading